New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies

Tuberculosis is the leading cause of death from a single infectious agent worldwide; therefore, the need for new antitubercular drugs is desperate. The recently validated target salicylate synthase MbtI is the first enzyme involved in the biosynthesis of mycobactins, compounds able to chelate iron,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pini, Elena, Poli, Giulio, Tuccinardi, Tiziano, Chiarelli, Laurent Roberto, Mori, Matteo, Gelain, Arianna, Costantino, Luca, Villa, Stefania, Meneghetti, Fiorella, Barlocco, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099841/
https://www.ncbi.nlm.nih.gov/pubmed/29933627
http://dx.doi.org/10.3390/molecules23071506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099841/
https://www.ncbi.nlm.nih.gov/pubmed/29933627
http://dx.doi.org/10.3390/molecules23071506

Ejemplares similares